Chemoinformaics analysis of ENT-16BETA,17-EPOXY-KAURANE
Molecular Weight | 288.475 | nRot | 0 |
Heavy Atom Molecular Weight | 256.219 | nRig | 22 |
Exact Molecular Weight | 288.245 | nRing | 5 |
Solubility: LogS | -6.193 | nHRing | 1 |
Solubility: LogP | 5.794 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 4 |
Atoms Count | 53 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 4 |
No. of Hydrogen atom | 32 | No. of Saturated Hetero Cycles | 1 |
No. of Carbon atom | 20 | No. of Saturated Rings | 5 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 55.5394 |
nHD | 0 | BPOL | 33.8386 |
QED | 0.559 |
Synth | 5.878 |
Natural Product Likeliness | 3.372 |
NR-PPAR-gamma | 0.025 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.015 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -5.029 |
MDCK | 0.0000188 |
BBB | 0.397 |
PPB | 0.97631 |
VDSS | 1.537 |
FU | 0.0213153 |
CYP1A2-inh | 0.052 |
CYP1A2-sub | 0.591 |
CYP2c19-inh | 0.127 |
CYP2c19-sub | 0.932 |
CYP2c9-inh | 0.221 |
CYP2c9-sub | 0.577 |
CYP2d6-inh | 0.189 |
CYP2d6-sub | 0.786 |
CYP3a4-inh | 0.52 |
CYP3a4-sub | 0.2 |
CL | 15.987 |
T12 | 0.052 |
hERG | 0.013 |
Ames | 0.018 |
ROA | 0.062 |
SkinSen | 0.151 |
Carcinogencity | 0.037 |
EI | 0.452 |
Respiratory | 0.944 |
NR-Aromatase | 0.737 |
Antiviral | No |
Prediction | 0.656426 |